Abstract
Heroin addiction imposes a devastating toll on society, with little known about its neurobiology. Excessive salience attribution to drug over non-drug cues/reinforcers, with concomitant inhibitory control decreases, are common mechanisms underlying drug addiction. While inhibitory control alterations generally culminate in prefrontal cortex (PFC) hypoactivations across drugs of abuse, patterns in individuals with heroin addiction (iHUD) remain unknown. We used a stop-signal fMRI task designed to meet recent consensus guidelines in mapping inhibitory control in 41 iHUD and 24 age- and sex-matched healthy controls (HC). Despite group similarities in the stop-signal response time (SSRT; the classic inhibitory control measure), compared to HC, iHUD exhibited impaired target detection sensitivity (proportion of hits in go vs. false-alarms in stop trials) (p=.003). Additionally, iHUD exhibited lower anterior and dorsolateral PFC (aPFC, dlPFC) activity during successful vs. failed stops (the hallmark inhibitory control contrast). Higher dlPFC/supplementary motor area (SMA) activity was associated with faster SSRT specifically in iHUD, and higher aPFC activity with better target sensitivity across all participants (p<.05-corrected). Importantly, in iHUD, the lower the SMA and aPFC activity during inhibitory control, the shorter the time since last use and the higher the severity of dependence, respectively (p<.05-corrected). Taken together, results revealed lower perceptual sensitivity and hypoactivations during inhibitory control in cognitive control regions (e.g., aPFC, dlPFC, SMA) as associated with task performance and addiction severity measures in iHUD. Such neurobehavioral inhibitory control deficits may contribute to self-control lapses in heroin addiction, constituting targets for prevention and intervention efforts to enhance recovery.
Significance statement Heroin addiction continues its deadly impact, with little known about its neurobiology. While behavioral and prefrontal cortical impairments in inhibitory control characterize addiction across drugs of abuse, these patterns have not been fully explored in heroin addiction. Here, we illustrate a significant behavioral impairment in target discrimination in individuals with heroin addiction compared to matched healthy controls. We further show lower engagement during inhibitory control in the anterior and dorsolateral prefrontal cortex (key regions that regulate cognitive control), as associated with slower stopping, worse discrimination, and addiction severity measures. Mapping the neurobiology of inhibitory control in heroin addiction for the first time, we identify potential treatment targets inclusive of prefrontal cortex-mediated cognitive control amenable for neuromodulation en route to recovery.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by 1R01AT010627 to RZG.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Icahn School of Medicine at Mount Sinai institutional review board approved study procedures, and all participants provided written informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
